StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.11+0.02 (+0.96%)

Close on Nov 17, 2026Market cap $214.68MP/E –Yield –

AC Immune operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

AC Immune's operating cash flow for the twelve months ending Dec 31, 2022 was -CHF 73.57M. For fiscal 2025 it was -CHF 69.26M, down 205.2% from the year before. The highest annual figure on record is CHF 65.84M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CHF 69.26M-205.2%
FY2024Dec 31, 2024CHF 65.84M–
FY2023Dec 31, 2023-CHF 60.41M–
FY2022Dec 31, 2022-CHF 73.57M–
FY2021Dec 31, 2021-CHF 65.69M–
FY2020Dec 31, 2020-CHF 59.52M-207.8%
FY2019Dec 31, 2019CHF 55.22M–
FY2018Dec 31, 2018-CHF 44.08M–
FY2017Dec 31, 2017-CHF 22.09M–
FY2016Dec 31, 2016-CHF 5.65M-112.8%
FY2015Dec 31, 2015CHF 44.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-CHF 17.41M–
Q3 FY2022Sep 30, 2022-CHF 13.54M–
Q4 FY2021Dec 31, 2021-CHF 17.83M–

More AC Immune figures

See a number that looks wrong?